HeartSciences Inc.: operating lease right-of-use asset

What this measure means

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Exact concept: us-gaap:OperatingLeaseRightOfUseAsset. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2022-04-30 to 2026-06-30. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• HeartSciences Inc.: total assets
• HeartSciences Inc.: total liabilities
• HeartSciences Inc.: stockholders equity
• HeartSciences Inc.: cash and cash equivalents
• HeartSciences Inc.: net income or loss
• HeartSciences Inc.: operating cash flow
• HeartSciences Inc.: capital expenditure payments
• HeartSciences Inc.: contract revenue excluding tax
• HeartSciences Inc.: financing cash flow
• HeartSciences Inc.: investing cash flow
• HeartSciences Inc.: retained earnings or deficit
• HeartSciences Inc.: basic weighted-average shares
• HeartSciences Inc.: diluted weighted-average shares
• HeartSciences Inc.: basic earnings per share
• HeartSciences Inc.: diluted earnings per share
• HeartSciences Inc.: net property, plant and equipment
• HeartSciences Inc.: share-based compensation expense
• HeartSciences Inc.: operating income or loss
• HeartSciences Inc.: current assets
• HeartSciences Inc.: interest expense
• HeartSciences Inc.: current liabilities
• HeartSciences Inc.: current accounts payable
• HeartSciences Inc.: net finite-lived intangible assets
• HeartSciences Inc.: net current accounts receivable
• HeartSciences Inc.: operating expenses
• HeartSciences Inc.: net inventory
• HeartSciences Inc.: gross profit
• HeartSciences Inc.: cost of revenue
• HeartSciences Inc.: selling, general and administrative expense
• HeartSciences Inc.: research and development expense
• HeartSciences Inc.: common shares outstanding
• HeartSciences Inc.: cash including restricted cash
• HeartSciences Inc.: additional paid-in capital
• HeartSciences Inc.: operating lease liability
• HeartSciences Inc.: gross property, plant and equipment
• HeartSciences Inc.: accumulated depreciation on property, plant and equipment
• HeartSciences Inc.: accrued current liabilities
• HeartSciences Inc.: depreciation expense
• HeartSciences Inc.: nonoperating interest expense
• HeartSciences Inc.: nonoperating income or expense
• HeartSciences Inc.: proceeds from issuing common stock
• HeartSciences Inc.: change in accounts receivable
• HeartSciences Inc.: change in inventories
• HeartSciences Inc.: change in accounts payable

Inspect the source

Entity

HeartSciences Inc. / CIK 0001468492

Captured

2026-09-20T09:07:08.448Z

SEC response SHA-256

5eb1d09e2fca60365f9ba9d3f414c7100583b832746ccd0994084f9b163bc76c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001468492.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))